Central Florida Retina is currently enrolling patients who are interested in participating in one of the following studies.
1| For patients who have been diagnosed with diabetic retinopathy
The primary objective of the study is to assess the efficacy of intravitreal (IVT) aflibercept compared to sham treatment in the improvement of moderately severe to severe nonproliferative diabetic retinopathy (NPDR).
2| For patients who have been diagnosed with alzheimer's disease
Phase 2/3 study to examine and test for retinal effects and visual changes while being administered disease specific study drug for dementia.
3| Genetic Studies
Study designed to observe and identify the risk factors that contribute to genetic Age Related Macular Degeneration.
Study designed to assist in Blood/DNA collection for the National Ophthalmic Disease Genotyping and Phenotyping Network.
Attention Patients and Doctors
If you are interested in obtaining more information or would like to enroll in one of these studies, please contact CFR’s Clinical Research Department at email@example.com.